Page 8 - CUA 2020_Pediatric
P. 8

2020 CUA Abstracts





        UP-2.15                                              ingly important. Prostate cancer treatment, albeit effective, is plagued
                                                                         3
        Mental health outcomes in men with a history of radical   by a host of life-altering side effects, such as bladder, bowel, and sexual
                                                                                                    4
        prostatectomy                                        dysfunction, as well as significant mental health issues.  Approximately
                                                                                                           5
                 1
                                                   1
                           1
                                      1
        Joshua White , Gabriela Ilie , David G. Bell , Gregory G. Bailly , Ricardo   60% of men with prostate cancer experience mental health distress,  with
                                                                                               6
        A. Rendon , Ross Mason , Joseph Lawen , Rob Rutledge 2  10–40% having clinically significant depression.  The goal of our study
                                    1
               1
                         1
        1 Department  of  Urology,  Dalhousie  University,  Halifax,  NS,   was to evaluate the associative role of age at diagnosis, urinary function,
               2
        Canada;  Department of Radiation Oncology, Dalhousie University,   multimorbidity, number of active forms of treatment, survivorship time,
        Halifax, NS, Canada                                  and social well-being on current mental health outcomes.
        Support: Soillse Prostate Cancer Quality of Life Research Lab. Dalhousie   Methods: A total of 129 men (mean age 62 years) with a history of prostate
        Research Medical Foundation                          cancer who received active treatment for their diagnosis completed an
        Introduction: Survivors of radical prostatectomy (RP) report poor quality-  online survey between May 2017 and December 2018, assessing patient-
        of-life outcomes.  We report the burden of mental health issues in a   reported quality-of-life outcomes. The primary outcome was a validated
                    1,2
        population-based cohort of men with a history of prostate cancer (PCa)   assessment of mental health disorder: the Kessler Psychological Distress
        who underwent RP to determine risk factors associated with poor mental   Scale (K10). Urinary problems and social well-being were assessed using
        health outcomes.                                     the UCLA Prostate Cancer Index and the Functional Assessment of Cancer
        Methods: A total of 144 men (aged 48–86 years, median 68) with a history   Therapy-Prostate (FACT-P), respectively. Analyses were controlled for age
        of PCa and RP completed an online survey from 2017–2018 assessing   at diagnosis, multimorbidity, number of received treatments to date, and
        patient-reported quality-of-life outcomes. The primary outcome was a   survivorship time.
        validated assessment of mental health disorder: the Kessler Psychological   Results: A total of 14.7% men scored positive for current mental health
        Distress Scale (0–50, with >20 being likely to have a mental health   issues. The fitted logistic model was statistically significant X2(8)=28.67;
        issue). Urinary problems were assessed using the International Prostate   p<0.001. A logistic model to help predict who is more likely to screen
        Symptom Score (0–35, with >7 indicating moderate/severe urinary symp-  positive for mental health issues revealed that better urinary function,
        toms). Relationship satisfaction was assessed using the validated Dyadic   increased social well-being, higher age at diagnosis, and longer survivor-
        Adjustment Scale (0–151, with >97 indicating relationship satisfaction).   ship time were associated with a decreased probability of having mental
        Analyses were controlled for age, comorbidities, and survivorship time.   health issues at 0.97 (95% confidence interval [CI] 0.95, 0.99), 0.15
        The analytical sample was 126. A multiple logistic analysis assessed the   (95% CI 0.03, 0.73), 0.91 (95% CI 0.83, 0.99), 0.98 (95% CI 0.97, 0.99),
        association between the stated predictors and current mental health status.  respectively. Multimorbidity, bowel, and sexual function did not contrib-
        Results: A total of 16.4% men scored positive for current mental health   ute statistically significantly to the model.
        issues; 60.3% of respondents reported mild urinary problems, while   Conclusions: Here, we show an association between a prostate can-
        39.7% reported moderate/severe urinary problems. The odds ratio (OR)   cer diagnosis and increased rates screening positive for mental distress
        was 4.49 (95% confidence interval [CI] 1.41,14.28) for presenting with   among men in the Maritime provinces. These findings highlight the
        mental health issues among men with moderate/severe urinary problems.   importance of a multidisciplinary approach to the prostate cancer care
        Being satisfied in a relationship was a protective factor for mental health   and survivorship, using the skillset of physicians, nurses, mental health
        issues (OR 0.2; 95% CI 0.05, 0.86), as was being older (OR 0.87; 95% CI   experts, and physiotherapists.
        0.79, 0.96). Survivorship time did not contribute statistically significantly   References
        to the model.                                        1.   Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA
        Conclusions: Men with prostate cancer undergoing RP are at increased   Cancer J Clin 2015;65:87-108. https://doi.org/10.3322/caac.21262
        risk of mental health illness.  In this study, we showed that younger men,   2.   Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J
                           2,3
        men with moderate/severe urinary symptoms, and men reporting relation-  Clin 2018;68:7-30. https://doi.org/10.3322/caac.21442
        ship dissatisfaction were found to be at higher risk for mental health issues.  3.   Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes
        References                                               after monitoring, surgery, or radiotherapy for prostate cancer. N Engl
        1.   Canadian Cancer Society’s Advisory Committee on Cancer Statistics.   J Med 2016;375:1425-37. https://doi.org/10.1056/NEJMoa1606221
            (2017). Canadian Cancer Statistics 2017. Toronto, ON: Canadian   4.   Spiegel D, Giese-Davis J. Depression and cancer: Mechanisms and
            Cancer Society.                                      disease progression. Biol Psychiatry 2003;54:269-82. https://doi.
        2.   Fervaha G, Izard JP, Tripp DA, et al. Depression and prostate can-  org/10.1016/S0006-3223(03)00566-3
            cer: A focused review for the cliician. Urol Oncol 2019;37:282-8.   5.   Steginga SK, Occhipinti S, Gardiner RA, et al. Prospective study of
            https://doi.org/10.1016/j.urolonc.2018.12.020        men’s psychological and decision-related adjustment after treatment
        3.   Isbarn H, Wanner M, Salomon G, et al. Long-term data on the   for localized prostate cancer. Urology 2004;63:751-6. https://doi.
            survival of patients with prostate cancer treated with radical prosta-  org/10.1016/j.urology.2003.11.017
            tectomy in the prostate-specific antigen era. BJU Int 2010;106:37-43.   6.   Mohamed NE, Bovbjerg DH, Montgomery GH, et al. Pretreatment
            https://doi.org/10.1111/j.1464-410X.2009.09134.x     depressive symptoms and treatment modality predict post-treatment
                                                                 disease-specific quality of life among patients with localized pros-
                                                                 tate cancer. Urol Oncol 2012;30:804-12. https://doi.org/10.1016/j.
        UP-2.16                                                  urolonc.2011.02.002
        An examination of the relationship between oncological
        treatment and biopsychosocial quality-of-life outcomes in
        Maritime prostate cancer survivors actively treated for their   UP-2.17
        malignancy                                           The androgen deprivation therapy educational program: A
                                                1
                                      1
        Tarek Lawen , Gabriela Ilie 1,2,3 , David Bell , Ross Mason , Gregory G.   Canadian resource that supports prostate cancer patients in
                 1
                                     1
                          1
            1
        Bailly , Ricardo A. Rendon , Joseph Lawen , Rob Rutledge 2  managing hormone therapy side effects
                                                                                     3
                                                                                               2
                                                                                                             1,2
                                                                          1,2
        1 Department  of  Urology,  Dalhousie  University,  Halifax,  NS,   Lauren M. Walker , Erik Wibowo , Carly S. Sears , John W. Robinson ,
                                                                           4
                                                                                         5
        Canada;  Department of Radiation Oncology, Dalhousie University,   Andrew G. Matthew , Deborah McLeod , Richard J. Wassersug 6
               2
                                                                                                       2
        Halifax,  NS,  Canada;  Department  of  Community  Health  and   1 Oncology, University of Calgary, Calgary, AB, Canada;  Oncology,
                          3
        Epidemiology, Dalhousie University, Halifax, NS, Canada  Division  of  Psychosocial  Oncology, Tom  Baker  Cancer  Centre,
                                                                             3
        Introduction: Prostate cancer is the second most common cancer in men   Calgary, AB, Canada;  Anatomy, University of Otago , Dunedin, New
                                                                    4
                                                1
        internationally and the fifth leading cause of cancer death.  Yet, prostate   Zealand;  Department of Surgical Oncology, Princess Margaret Cancer
                                                                                   5
        cancer carries one of the most favorable five-year survival rates of all   Centre, Toronto, ON, Canada;  Nursing, Dalhousie University , Halifax,
                                                                       6
                  2
        malignancies.  With over 1.1 million men diagnosed annually, focus on   NS, Canada;  Department of Cellular and Physiological Sciences,
        survivorship issues and patient-reported outcomes is becoming increas-  University of British Columbia, Vancouver, BC, Canada
        S64                                     CUAJ • June 2020 • Volume 14, Issue 6(Suppl2)
   3   4   5   6   7   8   9   10   11   12   13